Christine Le Beller
Inserm(FR)Université Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Européen Georges-Pompidou(FR)
Publications by Year
Research Areas
Pharmacovigilance and Adverse Drug Reactions, Drug-Induced Adverse Reactions, Antifungal resistance and susceptibility, Heparin-Induced Thrombocytopenia and Thrombosis, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Diagnostic score for heparin‐induced thrombocytopenia after cardiopulmonary bypass(2004)178 cited
- → Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug Reactions(2005)93 cited
- → Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients(2010)60 cited
- → Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database(2020)56 cited
- → Phenome-Wide Association Studies on a Quantitative Trait: Application to TPMT Enzyme Activity and Thiopurine Therapy in Pharmacogenomics(2013)55 cited
- → DPP4 inhibitor-induced polyarthritis: a report of three cases(2013)53 cited